Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.

Shapiro S, deVilliers TJ, Pines A, Sturdee DW, Archer DF, Baber RJ, Panay N, Farmer RD, Stevenson JC, Mueck AO, Burger HG, Gompel A.

J Natl Cancer Inst. 2014 Feb;106(2):djt372. doi: 10.1093/jnci/djt372. Epub 2013 Dec 22. No abstract available.

PMID:
24363446
[PubMed - indexed for MEDLINE]
2.

Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings: authors' response.

Shapiro S, Farmer RD, Stevenson JC, Burger HG, Mueck AO, Gompel A.

J Fam Plann Reprod Health Care. 2013 Jul;39(3):228-9. doi: 10.1136/jfprhc-2013-100673. No abstract available.

PMID:
23781084
[PubMed - in process]
3.

Does hormone replacement therapy (HRT) cause breast cancer? An application of causal principles to three studies.

Shapiro S, Farmer RD, Stevenson JC, Burger HG, Mueck AO, Gompel A.

J Fam Plann Reprod Health Care. 2013 Apr;39(2):80-8. doi: 10.1136/jfprhc-2012-100508.

PMID:
23493592
[PubMed - in process]
4.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies. Part 4: the Million Women Study.

Shapiro S, Farmer RD, Stevenson JC, Burger HG, Mueck AO.

J Fam Plann Reprod Health Care. 2012 Apr;38(2):102-9. doi: 10.1136/jfprhc-2011-100229. Epub 2012 Jan 16.

PMID:
22262621
[PubMed - in process]
5.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 2. The Women's Health Initiative: estrogen plus progestogen.

Shapiro S, Farmer RD, Mueck AO, Seaman H, Stevenson JC.

J Fam Plann Reprod Health Care. 2011 Jul;37(3):165-72. doi: 10.1136/jfprhc-2011-0090. Epub 2011 Jun 2.

PMID:
21642264
[PubMed - indexed for MEDLINE]
6.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen.

Shapiro S, Farmer RD, Mueck AO, Seaman H, Stevenson JC.

J Fam Plann Reprod Health Care. 2011 Oct;37(4):225-30. doi: 10.1136/jfprhc-2011-0091. Epub 2011 Jun 2.

PMID:
21642263
[PubMed - indexed for MEDLINE]
7.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: Part 1. The Collaborative Reanalysis.

Shapiro S, Farmer RD, Seaman H, Stevenson JC, Mueck AO.

J Fam Plann Reprod Health Care. 2011 Apr;37(2):103-9. doi: 10.1136/jfprhc.2011.0078.

PMID:
21454266
[PubMed - indexed for MEDLINE]
8.

Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database.

Seaman HE, Langley SE, Farmer RD, de Vries CS.

BJU Int. 2007 Jun;99(6):1398-403.

PMID:
17537215
[PubMed - indexed for MEDLINE]
9.

Systemic lupus erythematosus prevalence in the UK: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease.

Nightingale AL, Farmer RD, de Vries CS.

Pharmacoepidemiol Drug Saf. 2007 Feb;16(2):144-51.

PMID:
16700093
[PubMed - indexed for MEDLINE]
10.

Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database.

Nightingale AL, Farmer RD, de Vries CS.

Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):656-61.

PMID:
16389657
[PubMed - indexed for MEDLINE]
11.

Myocardial infarction risk and hormone replacement: differences between products.

de Vries CS, Bromley SE, Farmer RD.

Maturitas. 2006 Feb 20;53(3):343-50. Epub 2005 Jul 22.

PMID:
16040209
[PubMed - indexed for MEDLINE]
12.

Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.

Bromley SE, de Vries CS, Thomas D, Farmer RD.

Drug Saf. 2005;28(6):473-93. Review.

PMID:
15924502
[PubMed - indexed for MEDLINE]
13.

Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.

de Vries CS, Bromley SE, Thomas H, Farmer RD.

Drug Saf. 2005;28(3):241-9.

PMID:
15733028
[PubMed - indexed for MEDLINE]
14.

Incidence, prevalence and management of lower urinary tract symptoms in men in the UK.

Logie J, Clifford GM, Farmer RD.

BJU Int. 2005 Mar;95(4):557-62.

PMID:
15705080
[PubMed - indexed for MEDLINE]
15.

No risk of drug-associated liver injury with alpha1-adrenoreceptor blocking agents in men with BPH: results from an observational study using the GPRD.

Clifford GM, Logie J, Farmer RD.

Pharmacoepidemiol Drug Saf. 2005 Feb;14(2):75-80.

PMID:
15386708
[PubMed - indexed for MEDLINE]
16.

Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.

Seaman HE, de Vries CS, Farmer RD.

Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):427-36.

PMID:
15269926
[PubMed - indexed for MEDLINE]
17.

Ischemic stroke in young women: a nested case-control study using the UK General Practice Research Database.

Nightingale AL, Farmer RD.

Stroke. 2004 Jul;35(7):1574-8. Epub 2004 May 13.

PMID:
15143296
[PubMed - indexed for MEDLINE]
Free Article
18.

Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database.

Bromley SE, de Vries CS, Farmer RD.

BJOG. 2004 Apr;111(4):369-76.

PMID:
15008775
[PubMed - indexed for MEDLINE]
19.

The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD.

Seaman HE, de Vries CS, Farmer RD.

Pharmacoepidemiol Drug Saf. 2003 Oct-Nov;12(7):541-50.

PMID:
14558177
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk